1453-50-5 Usage
General Description
4-(2,5-DIMETHYLPHENYL)BUTYRIC ACID, also known as DMBA, is a chemical compound with the molecular formula C12H16O2. It is a derivative of butyric acid and contains a 2,5-dimethylphenyl group. DMBA is commonly used as a precursor in the synthesis of various pharmaceuticals and organic compounds. It is also used as a chiral auxiliary in asymmetric synthesis reactions. Additionally, DMBA has been studied for its potential role in the treatment of various medical conditions, including neurological disorders and cancer. 4-(2,5-DIMETHYLPHENYL)BUTYRIC ACID is considered to have low toxicity and is not known to pose significant health risks when handled and used properly.
Check Digit Verification of cas no
The CAS Registry Mumber 1453-50-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,4,5 and 3 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1453-50:
(6*1)+(5*4)+(4*5)+(3*3)+(2*5)+(1*0)=65
65 % 10 = 5
So 1453-50-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H11NO/c9-7(5-1-2-5)8-6-3-4-6/h5-6H,1-4H2,(H,8,9)
1453-50-5Relevant articles and documents
PROCESS FOR SYNTHESIZING 1,2,4-TRIAZOLES
-
Page/Page column 11, (2010/11/26)
The present invention relates to a process for production of 1,2,4-triazoles. The process comprises the reaction of a disubstituted amide and a hydrazide in the presence of POCl3.
TRIAZOLE DERIVATIVES AS INHIBITORS OF 11-BETA HYDROXYSTEROID DEHYDROGENASE-1
-
Page 33, (2008/06/13)
Triazole derivatives of structural formula I are selective inhibitors of the 11β-hydroxysteroid dehydrogenase-1. The compounds are useful for the treatment of diabetes, such as noninsulin-dependent diabetes (NIDDM), hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome, and other symptoms associated with NIDDM.